89 related articles for article (PubMed ID: 17334728)
1. Plasma concentration of micafungin in patients with hematologic malignancies.
Nakagawa Y; Ichii Y; Saeki Y; Kodaka M; Suzuki K; Kishino S
J Infect Chemother; 2007 Feb; 13(1):39-45. PubMed ID: 17334728
[TBL] [Abstract][Full Text] [Related]
2. Effect of liver and kidney function on migafungin disposition in patients with hematologic malignancies.
Nakagawa Y; Ichii Y; Saeki Y; Kodama M; Kishino S; Suzuki K
Eur J Drug Metab Pharmacokinet; 2008; 33(3):191-8. PubMed ID: 19007046
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the blood level of micafungin involving patients with hematological diseases: new findings regarding combination therapy with tacrolimus.
Shimoeda S; Ohta S; Kobayashi H; Saitou H; Kubota A; Yamato S; Shimada K; Sasaki M; Kawano K
Biol Pharm Bull; 2005 Mar; 28(3):477-80. PubMed ID: 15744072
[TBL] [Abstract][Full Text] [Related]
4. Penetration of micafungin into the burn eschar in patients with severe burns.
Sasaki J; Yamanouchi S; Sato Y; Abe S; Shinozawa Y; Kishino S; Aikawa N; Hori S
Eur J Drug Metab Pharmacokinet; 2014 Jun; 39(2):93-7. PubMed ID: 23771854
[TBL] [Abstract][Full Text] [Related]
5. The impact of total bilirubin on plasma micafungin levels in living-donor liver transplantation recipients with severe liver dysfunction.
Muraki Y; Iwamoto T; Kagawa Y; Sakurai H; Usui M; Isaji S; Uemoto S; Okuda M
Biol Pharm Bull; 2009 Apr; 32(4):750-4. PubMed ID: 19336919
[TBL] [Abstract][Full Text] [Related]
6. Effective blood concentration of micafungin for pulmonary aspergillosis.
Shimoeda S; Ohta S; Kobayashi H; Yamato S; Sasaki M; Kawano K
Biol Pharm Bull; 2006 Sep; 29(9):1886-91. PubMed ID: 16946503
[TBL] [Abstract][Full Text] [Related]
7. Ocular distribution of intravenously administered micafungin in rabbits.
Suzuki T; Uno T; Chen G; Ohashi Y
J Infect Chemother; 2008 Jun; 14(3):204-7. PubMed ID: 18574655
[TBL] [Abstract][Full Text] [Related]
8. Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits.
Groll AH; Mickiene D; Petraitis V; Petraitiene R; Ibrahim KH; Piscitelli SC; Bekersky I; Walsh TJ
Antimicrob Agents Chemother; 2001 Dec; 45(12):3322-7. PubMed ID: 11709303
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation.
Oshima K; Kanda Y; Kako S; Ohno K; Kishino S; Kurokawa M
Transpl Infect Dis; 2013 Jun; 15(3):323-7. PubMed ID: 23578224
[TBL] [Abstract][Full Text] [Related]
10. Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Yoshikawa K; Nakazawa Y; Katsuyama Y; Hirabayashi K; Saito S; Shigemura T; Tanaka M; Yanagisawa R; Sakashita K; Koike K
Infection; 2014 Aug; 42(4):639-47. PubMed ID: 24567233
[TBL] [Abstract][Full Text] [Related]
11. A comparative analysis of micafungin and caspofungin for empirical antifungal therapy in antibiotic-unresponsive febrile patients with hematologic malignancies.
Seko T; Usami E; Kimura M; Nakao T; Matsuoka T; Yoshimura T; Kanamori N; Tachi T; Teramachi H
Pharmazie; 2016 Aug; 71(8):484-488. PubMed ID: 29442037
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of micafungin for febrile neutropenia in pediatric patients with hematological malignancies: a multicenter prospective study.
Kobayashi R; Suzuki N; Yoshida M; Iizuka S; Suzuki D; Sano H; Kudoh T
J Pediatr Hematol Oncol; 2013 Oct; 35(7):e276-9. PubMed ID: 23743960
[TBL] [Abstract][Full Text] [Related]
13. [A liquid chromatographic method for quantifying unbound micafungin in human plasma and the relationship between the concentrations of unbound and total micafungin in plasma].
Noda K; Yokoyama T; Akiyama Y; Tadano K
Yakugaku Zasshi; 2013; 133(3):397-404. PubMed ID: 23208119
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of micafungin in febrile neutropenic patients treated for hematological malignancies.
Toubai T; Tanaka J; Ota S; Shigematsu A; Shono Y; Ibata M; Hashino S; Kondo T; Kakinoki Y; Masauzi N; Kasai M; Iwasaki H; Kurosawa M; Asaka M; Imamura M
Intern Med; 2007; 46(1):3-9. PubMed ID: 17202726
[TBL] [Abstract][Full Text] [Related]
15. Distribution of micafungin in the tissue fluids of patients with invasive fungal infections.
Yamada N; Kumada K; Kishino S; Mochizuki N; Ohno K; Ogura S
J Infect Chemother; 2011 Oct; 17(5):731-4. PubMed ID: 21537970
[TBL] [Abstract][Full Text] [Related]
16. Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults.
Keirns J; Sawamoto T; Holum M; Buell D; Wisemandle W; Alak A
Antimicrob Agents Chemother; 2007 Feb; 51(2):787-90. PubMed ID: 17116670
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction.
Hebert MF; Smith HE; Marbury TC; Swan SK; Smith WB; Townsend RW; Buell D; Keirns J; Bekersky I
J Clin Pharmacol; 2005 Oct; 45(10):1145-52. PubMed ID: 16172179
[TBL] [Abstract][Full Text] [Related]
18. Impact of plasma exchange on pharmacokinetic disposition of micafungin.
Konishi H; Fukushima K; Saotome T; Hamamoto T; Eguchi Y; Sudo M; Sumi M; Minouchi T; Iga I; Yamaji A
Ther Apher Dial; 2010 Jun; 14(3):358-63. PubMed ID: 20609192
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetic analysis of micafungin in Japanese patients with fungal infections.
Tabata K; Katashima M; Kawamura A; Kaibara A; Tanigawara Y
Drug Metab Pharmacokinet; 2006 Aug; 21(4):324-31. PubMed ID: 16946560
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
